1. Home
  2. EB vs ZURA Comparison

EB vs ZURA Comparison

Compare EB & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eventbrite Inc.

EB

Eventbrite Inc.

HOLD

Current Price

$4.45

Market Cap

442.9M

Sector

Technology

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$6.93

Market Cap

435.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EB
ZURA
Founded
2003
2022
Country
United States
United States
Employees
N/A
30
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
435.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
EB
ZURA
Price
$4.45
$6.93
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$5.00
$11.78
AVG Volume (30 Days)
1.1M
482.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
34.62
N/A
EPS
N/A
N/A
Revenue
$326,134,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.99
N/A
52 Week Low
$1.81
$0.99
52 Week High
$4.48
$7.19

Technical Indicators

Market Signals
Indicator
EB
ZURA
Relative Strength Index (RSI) 64.99 60.94
Support Level $4.43 $5.62
Resistance Level N/A N/A
Average True Range (ATR) 0.02 0.50
MACD -0.00 -0.00
Stochastic Oscillator 64.29 80.14

Price Performance

Historical Comparison
EB
ZURA

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: